Evidence map›Paper›PMID 29570839›Full record

ReviewJournal of neuroscience research2018

Transglutaminase 2: Friend or foe? The discordant role in neurons and astrocytes.

Breandan R Quinn, Laura Yunes-Medina, Gail V W Johnson

Open access · greenAbstract readReview
In one paragraph

Review in Journal of neuroscience research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Breandan R QuinnDepartment of Pharmacology and Physiology, University of Rochester, Rochester, New York.
Laura Yunes-MedinaDepartment of Neuroscience, University of Rochester, Rochester, New York.
Gail V W JohnsonDepartment of Pharmacology and Physiology, University of Rochester, Rochester, New York.ORCID 0000-0003-3464-0404
University of Rochester · US

Funding

The attenuation of ischemic injury by transglutaminase 2R01NS065825 · NINDS · UNIVERSITY OF ROCHESTER · PI JOHNSON, GAIL V. W. · 2011 to 2015
$1.8M
Defining CHOP-10 Dependent Adaptive ER Stress Pathways in NeuronsF31NS084672 · NINDS · UNIVERSITY OF ROCHESTER · PI YUNES-MEDINA, LAURA · 2013 to 2016
$170k
NINDS NIH HHS F31 NS084672NINDS NIH HHS R01 NS065825
6 · The paper itself

Abstract

Members of the transglutaminase family catalyze the formation of isopeptide bonds between a polypeptide-bound glutamine and a low molecular weight amine (e.g., spermidine) or the ɛ-amino group of a polypeptide-bound lysine. Transglutaminase 2 (TG2), a prominent member of this family, is unique because in addition to being a transamidating enzyme, it exhibits numerous other activities. As a result, TG2 plays a role in many physiological processes, and its function is highly cell type specific and relies upon a number of factors, including conformation, cellular compartment location, and local concentrations of Ca

Indexed as

AnimalsAstrocytesCell DeathGTP-Binding ProteinsHumansModels, MolecularNeuronsProtein Glutamine gamma Glutamyltransferase 2TransglutaminasesGTP-Binding ProteinsProtein Glutamine gamma Glutamyltransferase 2Transglutaminasesastrocytescell deathcytoskeletoninjuryneuritesneuronstranscription regulation

Identifiers

PMID29570839
PMCPMC5980740
OpenAlexW2792637435

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.